Finance

Beta
Lists
Q4 2026 earnings
See results
ASTRAZEN:NSE
Astrazeneca Pharma India Ltd
₹8,480.00
-1.94%
(-168.00) 1D
May 29, 3:30:01 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for ASTRAZEN...
Open
₹8,600.00
High
₹8,820.00
Low
₹8,431.50
Mkt. cap
216.69B
Avg. vol.
8.45K
Volume
29.55K
Dividend
0.38%
Quarterly dividend
₹8.00
Ex-dividend date
Jul 18, 2025
P/E ratio
105.50
52-wk high
₹10,691.00
52-wk low
₹7,551.50
EPS
₹80.38
Shares outstanding
25.00M
No. of employees
600
Open
₹8,600.00
High
₹8,820.00
Low
₹8,431.50
Mkt. cap
216.69B
Avg. vol.
8.45K
Volume
29.55K
Dividend
0.38%
Quarterly dividend
₹8.00
Ex-dividend date
Jul 18, 2025
P/E ratio
105.50
52-wk high
₹10,691.00
52-wk low
₹7,551.50
EPS
₹80.38
Shares outstanding
25.00M
No. of employees
600
News stories
From sources across the web
About Astrazeneca Pharma India Ltd
CEO-
Employees600
Founded1979
Headquarters-
SectorPharmaceutical industry
Websiteastrazeneca.in
Last report
May 26, 2026
Fiscal period
Q4 2026
EPS / Est. (INR)
- / -
Revenue / Est. (INR)
5.79B / -
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
5.26B
5.59B
6.12B
5.79B
Cost of goods sold
2.95B
3.24B
3.66B
3.94B
Cost of revenue
2.95B
3.24B
3.66B
3.94B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
864.70M
884.60M
1.30B
758.30M
Operating expense
1.66B
1.62B
2.04B
1.29B
Total operating expenses
4.62B
4.86B
5.71B
5.23B
Operating income
645.40M
726.10M
409.90M
553.10M
Other non operating income
112.40M
61.70M
51.30M
59.50M
EBT including unusual items
747.00M
728.20M
465.40M
581.40M
EBT excluding unusual items
750.60M
781.10M
450.60M
592.20M
Income tax expense
188.70M
186.00M
139.50M
132.60M
Effective tax rate
25.26%
25.54%
29.97%
22.81%
Other operating expenses
611.10M
655.10M
694.70M
394.50M
Net income
558.30M
542.20M
325.90M
448.80M
Net profit margin
10.61%
9.70%
5.33%
7.76%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-7.20M
-6.70M
-10.60M
-20.40M
Net interest expenses
-7.20M
-6.70M
-10.60M
-20.40M
Depreciation and amortization charges
165.70M
25.70M
38.40M
56.00M
EBITDA
729.48M
821.80M
493.98M
624.55M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer